Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
Nat Rev Clin Oncol
.
2024 Sep;21(9):701.
doi: 10.1038/s41571-024-00933-8.
Authors
Antonio Marra
1
,
Sarat Chandarlapaty
2
3
4
,
Shanu Modi
5
6
Affiliations
1
Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
2
Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4
Weill Cornell Medical College, New York, NY, USA.
5
Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. modis@mskcc.org.
6
Weill Cornell Medical College, New York, NY, USA. modis@mskcc.org.
PMID:
39095519
DOI:
10.1038/s41571-024-00933-8
No abstract available
Publication types
Published Erratum